Intravenous nipocalimab was administered from 14 to 35 weeks of gestation in participants with pregnancies at high risk for recurrent early-onset severe HDFN. HealthDay News — For pregnancies at high ...

Treatment with the monoclonal antibody nipocalimab improved live birth outcomes and delayed or prevented fetal anemia or intrauterine transfusions in pregnancies at high risk for early-onset severe ...

Please provide your email address to receive an email when new articles are posted on . Among pregnant women who received nipocalimab infusions, 54% had live births without an intrauterine transfusion ...

Data from a new investigational drug that could alter the standard treatment for a rare blood disease suggests it has the potential to delay or prevent anemia and the need for intrauterine blood ...

Doctors perform an Intrauterine Fetal Transfusion on an unborn baby at KNH. [Courtesy] A team of doctors including Rosa Chemwey, Flavia Ogutu, Ikol Adung'o and Kunjira Murayi at the Kenyatta National ...

A baby who contracted a virus when he was still in the womb is thought to be the youngest in the UK to receive a life-saving, rare blood transfusion procedure. Doctors discovered Arthur had caught ...

Intrauterine transfusion are needed for extremely unwell babies while they are still in the womb.

Please provide your email address to receive an email when new articles are posted on . Two postpartum hemorrhage-control devices resulted in similar rates of blood loss, transfusion and device ...

Doctors think Arthur Ransom is the youngest patient in the UK to have had a blood transfusion, delivered when his mother was ...